Molecular profiling of advanced malignancies guides first-line N-of-1 treatments in the I-PREDICT treatment-naïve study.

Autor: Sicklick, Jason K.1,2 (AUTHOR) jsicklick@health.ucsd.edu, Kato, Shumei2,3 (AUTHOR), Okamura, Ryosuke2,3 (AUTHOR), Patel, Hitendra2,3 (AUTHOR), Nikanjam, Mina2,3 (AUTHOR), Fanta, Paul T.2,3 (AUTHOR), Hahn, Michael E.4 (AUTHOR), De, Pradip5 (AUTHOR), Williams, Casey5 (AUTHOR), Guido, Jessica2 (AUTHOR), Solomon, Benjamin M.5 (AUTHOR), McKay, Rana R.2,3 (AUTHOR), Krie, Amy5 (AUTHOR), Boles, Sarah G.2,3 (AUTHOR), Ross, Jeffrey S.6,7 (AUTHOR), Lee, J. Jack8 (AUTHOR), Leyland-Jones, Brian5 (AUTHOR), Lippman, Scott M.2,3 (AUTHOR), Kurzrock, Razelle2,3 (AUTHOR) rkurzrock@health.ucsd.edu
Zdroj: Genome Medicine. 10/4/2021, Vol. 13 Issue 1, p1-14. 14p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje